Cysal

Cysal GmbH produces arginyl-aspartate and lysyl-aspartate (dipeptides) on an industrial scale by means of an internationally patented biotechnological process. The biotechnological company uses these dipeptides, i.e. the bond of two amino acids, as a basis for the production of specially developed end products such as energy tonics, skin creams, animal feed or infusion agents. In addition Cysal licences its technology to relevant industrial corporates.